Monica Bertagnolli: Celebrating Dr. Steven Rosenberg’s 50 Years at the National Cancer Institute
Monica Bertagnolli, Director of the National Institute of Health, shared a post on LinkedIn:
“In September, I was pleased to get the chance to take part in a special event honoring the groundbreaking work of Dr. Steven A. Rosenberg, the Chief of the Surgery Branch at the National Cancer Institute.
The event, called ‘Past, Present, and Future of Cellular Immunotherapy,’ was a two-day scientific symposium celebrating Steven’s 50 years at NCI. The symposium, which was held at the NIH Clinical Center, served as a wonderful tribute to his decades working to advance immunotherapy treatment for patients with cancer.
In my brief remarks to introduce Steven, I talked about his great impact on the field and how he served as an inspiration to me early in my career when I was an oncology resident and postdoc. His dedication to his work continues to inspire me.”
More posts featuring Monica Bertagnolli.
Monica Bertagnolli is the Director of the National Institute of Health (NIH), USA. She is the President of Alliance for Clinical Trials In Oncology Foundation.
She previously served as the Richard E. Wilson Professor of Surgery in the field of surgical oncology at Harvard Medical School, a surgeon at Brigham and Women’s Hospital, and a member of the Gastrointestinal Cancer Treatment and Sarcoma Centers at Dana-Farber Cancer Institute.
Dr. Bertagnolli is the Founding Chair of the minimal Common Oncology Data Elements (mCODE) executive committee and has held multiple positions nationally, including being Past President and Chair of the Board of Directors of the American Society of Clinical Oncology. In 2021, she was elected to the National Academy of Medicine, having previously served on the National Academies National Cancer Policy Forum.
Steven A. Rosenberg is an American cancer researcher and surgeon, serving as Chief of Surgery at the National Cancer Institute and Professor of Surgery at both the Uniformed Services University of Health Sciences and George Washington University.
He pioneered effective immunotherapies and gene therapy, becoming the first to successfully insert foreign genes into humans.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023